Affinage · Toxoplasma gondii

AP2X1

AP2 domain transcription factor AP2X-1 · UniProt S8G6D4

Annotated
2026-09-10
10 papers in source corpus 1 papers cited in narrative 5 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

AP2X-1 is a nuclear ApiAP2-family transcriptional repressor in Toxoplasma gondii that suppresses stage differentiation and sexual commitment to maintain the proliferative tachyzoite program (PMID:40823841). Expressed in tachyzoites and bradyzoites but downregulated in mature merozoites, AP2X-1 is required for efficient tachyzoite invasion and replication, and its loss increases bradyzoite differentiation (PMID:40823841). It acts through physical association with the HDAC3/MORC repressor complex, and genome-wide binding overlaps HDAC3/MORC occupancy at promoters of bradyzoite- and sexual stage-specific genes, where AP2X-1 promotes chromatin compaction and restricts accessibility (PMID:40823841). Consequent to this repression, knockout parasites derepress bradyzoite- and sexual-stage gene programs and give rise to a mixed population of tachyzoite-, bradyzoite-, merozoite-, and sporozoite-like cells, identifying AP2X-1 as a critical negative regulator of stage transitions (PMID:40823841). In vivo, loss of AP2X-1 attenuates virulence and reduces brain cyst formation, linking its repressive function to pathogenesis (PMID:40823841).

Mechanistic history

Synthesis pass · year-by-year structured walk · 5 steps
  1. 2025 Medium

    Whether AP2X-1 contributes to tachyzoite fitness and stage identity was unknown; knockout established it is required for invasion and replication and normally restrains bradyzoite differentiation.

    Evidence CRISPR knockout with invasion, replication, and differentiation phenotyping and immunofluorescence in T. gondii

    PMID:40823841

    Open questions at the time
    • Does not define which direct target genes drive the invasion/replication defect
    • Strain background not specified in the attribution
  2. 2025 Medium

    The molecular mechanism of repression was unknown; AP2X-1 was shown to associate with the HDAC3/MORC repressor complex and its loss derepresses bradyzoite- and sexual stage-specific genes, establishing it as a transcriptional repressor acting through this complex.

    Evidence Co-immunoprecipitation/complex association plus RNA-seq of knockout parasites in T. gondii

    PMID:40823841

    Open questions at the time
    • Interaction shown by complex association without reciprocal or structural validation of the AP2X-1–HDAC3/MORC contact
    • Whether AP2X-1 recruits the complex or vice versa is unresolved
  3. 2025 Medium

    Whether AP2X-1 binds target promoters directly and remodels chromatin was open; CUT&TAG and ATAC-seq showed binding overlapping HDAC3/MORC occupancy at stage-specific promoters and a role in chromatin compaction/accessibility.

    Evidence CUT&TAG genomic occupancy and ATAC-seq chromatin accessibility profiling in T. gondii

    PMID:40823841

    Open questions at the time
    • DNA sequence motif recognized by AP2X-1 not defined
    • Direct causality between binding and compaction versus indirect effects not dissected
  4. 2025 Medium

    The breadth of stage programs controlled by AP2X-1 was unclear; single-cell RNA-seq of the knockout revealed emergence of tachyzoite-, bradyzoite-, merozoite-, and sporozoite-like cells, establishing AP2X-1 as a negative regulator of sexual commitment and stage transitions.

    Evidence Single-cell RNA sequencing of knockout T. gondii

    PMID:40823841

    Open questions at the time
    • Does not establish whether derepressed cells are functionally competent for the full sexual cycle
    • Temporal ordering of stage-fate decisions not resolved
  5. 2025 Medium

    Whether the repressive function affects pathogenesis was unknown; knockout attenuated virulence and decreased brain cyst formation in mice, linking AP2X-1 repression to in vivo disease.

    Evidence Mouse infection model with virulence and brain cyst quantification

    PMID:40823841

    Open questions at the time
    • Does not separate the contribution of invasion/replication defects from stage-derepression to attenuation
    • Single-lab in vivo result

Open questions

Synthesis pass · forward-looking unresolved questions
  • The DNA-binding specificity of AP2X-1 and the direction of recruitment within the HDAC3/MORC complex remain undefined.
  • No AP2X-1 binding motif reported
  • No structural or reciprocal validation of the HDAC3/MORC association
  • Mechanism of complex recruitment to stage-specific promoters unknown

Mechanism profile

Synthesis pass · controlled-vocabulary classification
Partners
Complex memberships
HDAC3/MORC repressor complex

Evidence

Reading pass · 5 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2025 AP2X-1 is expressed during tachyzoite and bradyzoite stages but decreases in the mature merozoite stage; knockout of ap2X-1 significantly impaired tachyzoite invasion and replication while increasing the frequency of bradyzoite differentiation. CRISPR-based gene knockout, phenotypic assays (invasion, replication), immunofluorescence mBio Medium 40823841
2025 AP2X-1 physically associates with the HDAC3/MORC repressor complex, and loss of ap2X-1 leads to upregulation of bradyzoite- and sexual stage-specific genes, indicating AP2X-1 functions as a transcriptional repressor of these gene sets through this complex. Co-immunoprecipitation/complex association assay, RNA-seq transcriptomics after knockout mBio Medium 40823841
2025 CUT&TAG analysis revealed substantial overlap between AP2X-1 genomic binding and HDAC3/MORC complex occupancy at promoters of bradyzoite- and sexual stage-specific genes, and ATAC-seq demonstrated that AP2X-1 influences chromatin compaction and accessibility at these loci. CUT&TAG (Cleavage Under Targets and Tagmentation), ATAC-seq mBio Medium 40823841
2025 Single-cell RNA sequencing of the ap2X-1 knockout strain revealed a mixed population including tachyzoite-, bradyzoite-, merozoite-, and sporozoite-like parasites, indicating AP2X-1 is a critical negative regulator of sexual commitment and stage transitions. Single-cell RNA sequencing (scRNA-seq) of knockout parasites mBio Medium 40823841
2025 Loss of ap2X-1 resulted in significant attenuation of T. gondii virulence and decreased brain cyst formation in vivo, consistent with its role in repressing bradyzoite differentiation and sexual commitment. Mouse infection model (in vivo virulence assay, brain cyst counting) mBio Medium 40823841

Source papers

Stage 0 corpus · 10 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2010 Coordinated progression through two subtranscriptomes underlies the tachyzoite cycle of Toxoplasma gondii. PloS one 234 20865045
2018 The Epigenome, Cell Cycle, and Development in Toxoplasma. Annual review of microbiology 51 29932347
2010 The construction and use of log-odds substitution scores for multiple sequence alignment. PLoS computational biology 48 20657661
2012 Cactin is essential for G1 progression in Toxoplasma gondii. Molecular microbiology 23 22486860
2014 Distinct strains of Toxoplasma gondii feature divergent transcriptomes regardless of developmental stage. PloS one 22 25393307
2008 New eukaryotic systematics: a phylogenetic perspective of developmental gene expression in the Apicomplexa. International journal for parasitology 12 18983845
2024 Apicomplexan mitoribosome from highly fragmented rRNAs to a functional machine. Nature communications 9 39690155
2022 Genomic insights into host and parasite interactions during intracellular infection by Toxoplasma gondii. PloS one 2 36178892
2025 AP2X-1 is a negative regulator of Toxoplasma gondii sexual commitment. mBio 1 40823841
2026 Host-cell dependent epigenetic profiles associated with survival outcomes in T. gondii infection. Epigenetics & chromatin 0 42087241